PRO-APOPTOTIC miRs |
miR-7-5p |
PSME3 |
Inhibits cell proliferation and induces apoptosis in vitro and in vivo
|
MDA-MB-231, MCF7, and nude mice |
Shi et al., 2015
|
2.08 |
S |
miR-15/16 |
RPS6KB1 |
Inhibits cell proliferation and promotes cell cycle arrest and caspase-3 dependent apoptosis |
MDA-MB-231, MCF7 |
Janaki Ramaiah et al., 2014
|
1.71, 1.44 |
S, S |
miR-15a-5p |
SNCG, CCNE1 |
Mediates cell cycle arrest and promotes cell apoptosis |
MDA-MB-231, MDA-MB-231 |
Luo et al., 2013
|
1.71 |
S |
miR-15a-3p |
BCL2L1 |
Inhibits the expression of BCL2L1 and activates caspase-3/7 activity to promote apoptosis |
MDA-MB-231 |
Druz et al., 2013
|
ND |
ND |
miR-16-5p |
CCND1, BCL2, METTL13 |
Decreases cell growth and proliferation and induces apoptosis. Repression of METTL13 by miR-16 promotes apoptosis of cancer cells |
MCF7 |
Rivas et al., 2012
|
1.44 |
S |
mir-24-2-5p |
BCL-2 |
mir-24-2-5p induces apoptosis by targeting BCL-2 |
MCF7 |
Srivastava et al., 2011
|
ND |
ND |
miR-26a |
MTDH, EZH2, MCL1 |
Induces cell apoptosis and suppresses tumorigenesis in vivo
|
MCF7, MDA-MB-231, and nude mice |
Zhang et al., 2011; Gao et al., 2013
|
0.72 |
S |
|
|
Repression of MCL1 by miR-26a suppresses cell growth and proliferation |
|
|
|
|
miR-26b |
SLC7A11 |
Impairs viability and induces cell apoptosis |
MCF7 |
Liu X. X. et al., 2011
|
0.83 |
S |
miR-31 |
PRKCE (PKCϵ) |
Enhances cell apoptosis, inhibits oncogenic NF-κB pathway and brings about indirect downregulation of BCL2 |
MCF10A, MDA-MB-231. |
Körner et al., 2013
|
1.07 |
NS |
miR-34a |
BCL2, SIRT1, FRA1, LMTK3, AXL, NOTCH1, LDHA |
Suppresses cells proliferation, glycolysis, migration, invasion, and induces apoptosis. Reduces cancer stem cell properties and increases sensitivity to doxorubicin treatment. |
MCF7, MDA-MB-231, BT549, Hs578T, and nude mice |
Mackiewicz et al., 2011; Li et al., 2013; Yang et al., 2013; Zhao et al., 2013; Park et al., 2014; Xiao et al., 2016
|
1.09 |
NS |
miR-124 |
Ets-1 |
Induces cell apoptosis, reduces cell proliferation, and colony formation. |
MCF7, MDA-MB-231. |
Li W. et al., 2014
|
1.1 |
S |
miR-125a |
ELAVL1 |
Promotes apoptosis and inhibits cell growth and proliferation |
MCF7 |
Guo et al., 2009
|
0.68 |
S |
miR-125b |
MUC1, EPO, EPOR, ENPEP, CK2-α, CCNJ, MEGF9, ERBB2, ARID3B |
miR-125b promotes DNA damage-induced apoptosis and regulates cell motility |
ZR-75-1, BT549, MCF7, MDA-MB-231 |
Rajabi et al., 2010; Akhavantabasi et al., 2012; Feliciano et al., 2013; Ferracin et al., 2013
|
0.27 |
S |
miR-145 |
RTKN, c-Myc |
Induces cell apoptosis and inhibits cancer cell growth |
MCF7 |
Sachdeva et al., 2009; Wang et al., 2009
|
0.17 |
S |
miR-146a/b |
IRAK1, TRAF6 |
Mediates tumor suppression and triggers apoptosis |
MCF7 |
Liu et al., 2015
|
1.11, 1.54 |
NS, S |
miR-290-3p |
ARID4B |
miR-290 enhances ER signaling and increases apoptosis thereby suppressing breast cancer progression |
6DT1, MVT-1 |
Goldberger et al., 2013
|
ND |
ND |
miR-486-5p |
PIM-1 |
Suppresses cell proliferation in vitro and in vivo, induces G0/G1 arrest, and promotes apoptosis |
MDA-MB-231, T47D and nude mice |
Zhang et al., 2014
|
0.07 |
S |
miR-497 |
Bcl-w (Bcl2L2) |
Inhibits cellular growth and enhances apoptosis, promotes G0/G1 cell phase arrest |
MCF7 |
Shen et al., 2012
|
0.38 |
S |
miR-502-5p |
TRAF2 |
Enhances early apoptosis and inhibits proliferation of breast cancer cells |
MCF7, MDA-MB-231, and MCF-10A |
Sun et al., 2014
|
ND |
ND |
miR-769-3p |
NDRG1 |
Inhibits cell proliferation and enhances apoptosis |
MCF7 |
Luo et al., 2014
|
ND |
ND |
miR-874 |
CDK9 |
Induces cell apoptosis and inhibits cell proliferation and brings about cell cycle arrest |
MCF7, MDA-MB-231 |
Wang L. et al., 2014
|
0.77 |
S |
miR-99a |
mTOR |
Induces cell apoptosis and suppresses cell viability |
MCF7, MDA-MB-231 |
Hu et al., 2014
|
0.22 |
S |
ANTI-APOPTOTIC miRs |
miR-21 |
BCL2, TIMP3, PDCD4, PTEN, TPM1, MASPIN, ANKRD46 |
miR-21 inhibition suppress both cell growth in vitro and tumor growth in vivo miR-21 promotes invasion in breast cancer cells |
MCF7, MDA-MB-231, MDA-MB-435, and nude mice |
Zhu et al., 2007; Frankel et al., 2008; Yang et al., 2009; Song et al., 2010; Wang et al., 2011; Yan et al., 2011
|
4.81 |
S |
miR-24-3p |
p27Kip1 |
Promotes cell proliferation and inhibits cell apoptosis |
MDA-MB-435, MDA-MB-468 |
Lu et al., 2015
|
0.94 |
NS |
miR-100 |
MTMR3 |
Antagonism of miR-100 led to G2/M cell-cycle arrest and induce apoptosis |
SK-BR-3 |
He et al., 2015
|
0.23 |
S |
miR-155 |
FOXO3a, SOCS1, RHOA |
Induces cell survival and plays an important role in chemoresistance in breast cancer. |
MCF7, MDA-MB-231 |
Kong et al., 2008, 2010; Jiang et al., 2010
|
2.24 |
S |
miR-155 |
TP53INP1 |
miR-155 mediates cell proliferation and inhibits cell apoptosis |
MCF7 |
Zhang et al., 2013
|
2.24 |
S |
miR-96/182 |
PFN1, FOXO1 |
miR-182 promotes proliferation and invasion and inhibits apoptosis of breast cancer cells |
MDA-MB-231, MCF7 |
Guttilla and White, 2009; Liu et al., 2013
|
miR-182 (5.31) |
S |
|
|
|
|
|
miR-96 (7.35) |
S |
miR-196a |
ANXA1 |
Enhances cell proliferation, colony formation and suppresses apoptosis |
T47D, MDA-MB-453, MDA-MB-231 |
Luthra et al., 2008
|
5.12 |
S |
miR-221/222 |
PTEN, PUMA, CASP3, p27Kip1 |
Enforced expression of miR-221/222 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis by targeting and blocking caspase-3 expression |
MCF7, SKBR3, HCC1500, MDA-MB- 231, |
Miller et al., 2008; Zhang et al., 2010; Ergun and Oztuzcu, 2014; Li et al., 2016
|
miR-221 (0.81), miR-222 (0.79) |
S, S |
miR-210 |
RAD52, GPD1L |
miR-210 overexpression inhibits apoptosis |
MCF7 |
Crosby et al., 2009; Fasanaro et al., 2009
|
5.46 |
S |
miR-504 |
P53 |
miR-504 overexpression reduces p53 mediated apoptosis and cell cycle arrest in response to stress |
MCF7 and nude mice |
Hu et al., 2010
|
0.73 |
S |